Similarly, Ogura Y et al. found that inflammatory markers, such as neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP)-to-albumin ratio, and advanced lung cancer inflammation index, were significantly correlated with survival outcomes in patients treated with chemoimmunotherapy [11]. The gene discussed is CRP; the disease is lung carcinoma.